The Sanger sequencing service market is expected to reach US$ 2,292.71 million by 2031 with a CAGR of 13.3%.Key drivers of market growth include increasing demand for genetic information and advances in technology.The North American region dominates the market in terms of market share in 2023.Major players in the Sanger sequencing market include Microsynth AG, Laragen, Inc., Thermo Fisher Scientific, etc.